Trial Planning & Design
A robust trial design is essential to ensure a successful outcome. The trial design should be considered before developing the protocol. This will help ensure that all necessary practical requirements are identified early so that adequate funds are requested.
A well-documented study plan will facilitate the process of developing funding applications, ethics committee and R&D approvals / NHS permissions, and any necessary regulatory approvals.
Successful trials often share similar characteristics. They are:
- Conceptually simple and tailored to the patient group
- Address questions of clinical relevance where genuine uncertainties exist
- Avoid unnecessarily complex/restrictive entry criteria to ensure generalisability, where appropriate
- Avoid unnecessarily complex data requirements (resulting from a careful justification of each data point to be collected)
- Ensure the most appropriate choice of control arm (where appropriate)
- Ensure robust allocation concealment (where possible)
- Ensure robust blinding of intervention or appropriately blinded outcome assessments (where appropriate).
It is important to collaborate with a statistician who can help with:
- Designing your trial
- Choosing an appropriate outcome
- Providing justification of the sample size
- Advising on appropriate randomisation methodology
- Drawing up a statistical analysis plan
- Handling and structuring collected data
- Preparing and presenting interim reports to Data Monitoring Committees (DMCs), if applicable.
Patient and public involvement (PPI) is important to ensure that the question proposed is important and relevant to the people it directly affects and that the trial is practical and feasible. There is now a growing evidence base to support the positive impact that PPI can have on participation recruitment and retention in clinical trials. Many funders will require evidence of genuine involvement as a condition of funding.
If you are planning extensive public involvement in your research, you might want to consider assessing the impact of this using a tool such as the Public Involvement Impact Assessment Framework (PiiAF).
The National Context:
When initiating a trial, researchers should familiarise themselves with the framework in place for conducting trials. In particular:
1) The role of the National Institute of Health Research (NIHR), the process and criteria for inclusion of research on the NIHR Clinical Research Network Portfolio and the importance of public and patient involvement when conducting research.
The NIHR Research Design Service (RDS) supports researchers in England to develop and design high quality research proposals for submission to NIHR and other national, peer-reviewed funding competitions for applied health or social care research (see Funding Proposal station).
2) The role of the UK Clinical Research Collaboration (UKCRC), which provides information on the infrastructure for research in the UK. Their web pages include information on Clinical Research Network and Clinical Trial Units (CTUs), including the process for identifying CTUs that may have expertise in coordinating multi-site research in different disease areas or with different trial designs (see UKCRC Registered CTU Networks).
3) The critical path for undertaking a clinical trial can be complex. The RD Info Research Process Flow Chart gives an overview of the process. The positioning of the stations on the route maps within this Toolkit also indicate which activities can be conducted in parallel and which activities should be completed before moving on the to the next stage.
For those new to managing trials, the NIHR Trial Managers Network (TMN) is a source of practical support and guidance on the trial management process.
The Network and individual Hubs also offer assistance to colleagues based in Clinical Trials Units and the Research Design Service when they receive enquiries, through the Methodology Advisory Service for Trials.
Core Outcome Measures for Trials
The COMET (Core Outcome Measures in Effectiveness Trials) Initiative brings together people interested in the development and application of agreed standardised sets of outcomes, known as ‘core outcome sets’ (COS). These sets represent the minimum that should be measured and reported in all clinical trials of a specific condition, and are also suitable for use in clinical audit or research other than randomised trials.
The COMET database contains information on published and ongoing core outcome set studies, and is regularly updated. The COMET initiative also supports workshops, presentations and meetings promoting the use of core outcome sets.
- HRA Guidance on questions that need answering when designing clinical trials: The Health Research Authority has published useful guidance to clarify which questions researchers, sponsors, peer reviewers, and ethics committees should ask when planning or reviewing clinical studies.
- NIHR Trials Overview: A website resource pulling together information and advice on key trials related activity including methods.
- MRC Ethics Series: Good Research Practice: Information published by the MRC giving guidelines on conducting research with human participants and their tissues and data
- Planning a Randomised Controlled Trial: Points to Consider : A paper summarising some of the trial activities that would need to be considered
- The NHS Research & Development Forum: The NHS R&D Forum is a network for those involved in managing and supporting R&D in health and social care. Information on key activities and developments is regularly updated.
- In England, SOPs developed by sponsor and host organisation conducting studies in should meet the requirements of the Research Support Services (RSS) framework and RSS documents relevant to this station include:
- Annex4-P02-Planning Toolkit for PARTICIPATING Organisation, May 2011
- Annex5-S05-Planning Toolkit for SPONSORING Organisation, May 2011.
- Trainees Clinical Trial Guidance Guidance to support NIHR trainees interested in getting involved in clinical trials
- DIRUM is an open-access Database of Instruments for Resource Use Measurement.
- Recommendations for the design of MAMS (multi-arm multi-stage) trials.
Lancet Series on Research Waste:
- Avoidable waste in the production and reporting of research evidence by I Chalmers & P Glasziou.
- Increasing value and reducing waste in research design, conduct, and analysis by J Ioannidis et al.
Other Toolkits available:
- Data and Tissue Toolkit: Practical help with the legislative and good practice requirements relating to the use of personal information and human tissue samples in healthcare research in the UK
- Stem Cell Toolkit: A regulatory tool for those conducting stem cell research in the UK.
- Experimental Medicine Toolkit: For investigators, R&D Managers and ethics committees involved in experimental medicine studies.
Further resources on Patient and Public Involvement:
- INVOLVE is a national advisory group that supports public involvement. The INVOLVE website has a wealth of useful resources including briefing notes for researchers.
- NETSCC Public Involvement Pages
- The People in Research website can be used to help find public contributors to involve in research, or for public contributors to find opportunities to get involved in research.
- The Joint Health and Social Care Regulators’ Patient and Public Involvement Group have produced a useful handbook on good practice in PPI.
- Your local NIHR Research Design Service can provide valuable PPI advice on developing research proposals, including the involvement of patients and the public. The RDS PPI Handbook has been created to help researchers plan, manage and implement PPI activities.
- Healthtalk.org showcases a range of different experiences in healthcare including participation and involvement in health research.